Ontology highlight
ABSTRACT: Significance
We describe the identification of a heretofore unrecognized ubiquitin ligase complex that prevents the aberrant activation of the ISR in a subset of cancer cells. This provides a novel insight on the regulation of ISR and exposes a therapeutic opportunity to selectively eliminate these cancer cells. See related commentary Leli and Koumenis, p. 535. This article is highlighted in the In This Issue feature, p. 517.
SUBMITTER: Cervia LD
PROVIDER: S-EPMC9975667 | biostudies-literature | 2023 Mar
REPOSITORIES: biostudies-literature
Cervia Lisa D LD Shibue Tsukasa T Borah Ashir A AA Gaeta Benjamin B He Linh L Leung Lisa L Li Naomi N Moyer Sydney M SM Shim Brian H BH Dumont Nancy N Gonzalez Alfredo A Bick Nolan R NR Kazachkova Mariya M Dempster Joshua M JM Krill-Burger John Michael JM Piccioni Federica F Udeshi Namrata D ND Olive Meagan E ME Carr Steven A SA Root David E DE McFarland James M JM Vazquez Francisca F Hahn William C WC
Cancer discovery 20230301 3
Systematic identification of signaling pathways required for the fitness of cancer cells will facilitate the development of new cancer therapies. We used gene essentiality measurements in 1,086 cancer cell lines to identify selective coessentiality modules and found that a ubiquitin ligase complex composed of UBA6, BIRC6, KCMF1, and UBR4 is required for the survival of a subset of epithelial tumors that exhibit a high degree of aneuploidy. Suppressing BIRC6 in cell lines that are dependent on th ...[more]